| Patents for C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565) |
|---|
| 04/15/2004 | WO2004031199A2 Lipid-analog phosphoric acid triester |
| 04/15/2004 | DE10245909A1 Lipidanaloge Phosphorsäuretriester Lipid analogs phosphoric triester |
| 03/16/2004 | US6706701 6, 7-oxygenated steroids and uses related thereto |
| 03/11/2004 | WO2003079961A3 Method for producing 7$g(a)-methyl steroids |
| 03/04/2004 | US20040043976 16Alpha-methyl or ethyl substituted estrogens |
| 03/04/2004 | US20040043972 Autoimmune disease; antidiabetic agents |
| 02/24/2004 | CA2309796C Carbonate derivatives of retinol, process for their preparation and uses |
| 01/28/2004 | CN1470241A Astragalus root methyl-glycoside composition and preparation method |
| 01/27/2004 | US6683197 Process for the production of 4,4-dimethyl-5α-cholesta-8,14,24-trien-3β-01 and intermediate products in process (I) |
| 01/27/2004 | CA2069483C Steroid sulphatase inhibitors |
| 01/21/2004 | EP1381357A2 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 01/20/2004 | CA2123051C Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 01/15/2004 | US20040010138 Process for the production of 7alpha-methyl steroids |
| 01/13/2004 | US6677329 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 12/31/2003 | WO2004000869A1 Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 12/30/2003 | US6670393 Carbamate-based cationic lipids |
| 12/24/2003 | DE10213371C1 Verfahren zur Herstellung von 7alpha-Methylsteroiden Process for the preparation of 7alpha-methyl steroids |
| 12/18/2003 | US20030232791 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 12/17/2003 | CN1131237C Usage of steroi saponin for preventing and curing senile dementia and new steroi saponin |
| 11/20/2003 | WO2003095470A1 Platinum complexes having antitumor activity |
| 11/20/2003 | WO2003095462A2 Platinum complexes containing chemically modified bile acids, having antitumor activity |
| 11/20/2003 | WO2003094971A1 Cationic lipids for intracellular delivery of bioactive substances |
| 11/20/2003 | CA2485431A1 Platinum complexes having antitumor activity |
| 11/19/2003 | EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 10/21/2003 | CA2130926C Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof |
| 10/21/2003 | CA2093896C Hormone labelling with rhenium and technetium |
| 10/08/2003 | EP0994884B1 Diphosphonic acid salts for the treatment of osteoporosis |
| 10/07/2003 | CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays |
| 10/02/2003 | WO2003079961A2 Method for producing 7$g(a)-methyl steroids |
| 09/24/2003 | CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
| 09/24/2003 | CN1444596A 16 alpha-methyl or ethyl substituted estrogens |
| 09/23/2003 | CA2082936C Fluorescent porphyrin, and fluorescent phthalocyanine-polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |
| 09/18/2003 | WO2003075931A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |
| 09/18/2003 | US20030175751 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis |
| 09/18/2003 | CA2478931A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |
| 09/17/2003 | EP1070082B1 Method for producing 4,4-dimethyl-5alpha-cholesta-8,14,24-triene-3beta-ol and intermediate products obtained by said method |
| 09/10/2003 | CN1120843C Isomerisation of equilin |
| 09/03/2003 | EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 09/03/2003 | EP0767798B1 Sterol derivatives used for regulation of meiosis |
| 08/05/2003 | CA2082934C Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents |
| 07/30/2003 | EP1331011A2 Derivatized oligonucleotides having improved uptake and other properties |
| 07/24/2003 | WO2003059931A1 PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS |
| 07/15/2003 | US6593301 Ligosaccharide glycosides derived from spirostane with high effective and low side action wherein the dementia is Alzheimer's disease, vascular dementia, or mixed type dementia |
| 07/01/2003 | CA2089194C Steroid derivatives |
| 06/17/2003 | US6579995 Process for phosphorylation and compounds produced by this process |
| 06/17/2003 | US6579864 Arthritic diseases and/or autoimmune diseases |
| 06/17/2003 | CA2096020C 2.beta.,19-methyleneamino bridged steroids as aromatase inhibitors |
| 06/05/2003 | US20030104360 Synthetic receptors, libraries and uses thereof |
| 06/03/2003 | US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability |
| 05/22/2003 | US20030097011 Novel carbamate-based cationic lipids |
| 05/07/2003 | EP1307471A1 16alpha-methyl or ethyl substituted estrogens |
| 05/07/2003 | EP0724447B1 Derivatized oligonucleotides having improved uptake |
| 05/02/2003 | EP0811006B1 Benzopyran-containing compounds and method for their use |
| 04/23/2003 | EP1304333A2 6,7-Oxygenated steroids and uses related thereto |
| 04/17/2003 | WO2000011017A3 Cardenolide complexes useful as cardioactive agents |
| 04/17/2003 | US20030073640 Novel compositions for the delivery of negatively charged molecules |
| 04/15/2003 | CA2084775C Method of treating human prostatic adenocarcinoma |
| 04/03/2003 | US20030064492 Nucleotide sequences for use as tool in human therapeutics and diagnostics |
| 04/02/2003 | EP0738157B1 Contrast media for x-ray and magnetic resonance imaging |
| 03/12/2003 | CN1402734A 3-methylene steroid deriv. |
| 03/05/2003 | EP1287017A1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
| 03/05/2003 | EP1140972B1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 02/25/2003 | CA2078804C Manufacture and use of novel glycosides of catechol estrogens |
| 02/19/2003 | EP1284273A2 Estra-1,3,5(10)-trien-3-sulfamates a process for their production and pharmaceutical compositions containing them |
| 02/12/2003 | EP1023314B1 Bile acid salts of metals with physiological action and the use thereof in therapy |
| 02/12/2003 | EP0863906B1 Heterocyclic dioxethane substrates, process for their preparation and their use |
| 02/12/2003 | EP0614463B1 Angiostatic steroids |
| 01/21/2003 | US6509324 Use as contrast agents in magnetic resonance imaging |
| 01/16/2003 | US20030013859 Use as contrast agents in magnetic resonance imaging |
| 01/09/2003 | WO2002072084A8 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 01/08/2003 | EP1273590A2 Estra- 1,3,5(10)-triene Derivatives, Methods of Preparing Such Compounds and Pharmaceutical Compositions Containing Them |
| 01/02/2003 | US20030004148 Regulation of meiosis |
| 12/11/2002 | EP1100805B1 Medicine nitrate salts |
| 12/10/2002 | CA2084313C Process for the production of 10beta-h-steroids |
| 12/04/2002 | EP0984980B1 20-aralkyl-5alpha-pregnane derivatives |
| 12/04/2002 | EP0917534B1 6,7-oxygenated steroids and uses related thereto |
| 11/21/2002 | WO2002072084A3 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 11/21/2002 | WO2001042273A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 10/24/2002 | US20020156051 Atherosclerosis and hyperlipidemia; ascorbic acid and anticholesterol agents that are 3-hydroxy-3-methyl glutaryl coenzyme-A reductase inhibitors |
| 10/15/2002 | CA2038985C Haloethyl-substituted steroidal enzyme inhibitors |
| 10/02/2002 | CN1372565A Non-aromatic estrogenic steroids with hydrocarbon substituent in position 11 |
| 09/26/2002 | WO2002022645A3 Method of making 7alpha-methyl-11beta-methoxy estradiol and related compounds with estrogenic activity |
| 09/19/2002 | WO2002072084A2 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 09/18/2002 | EP1240179A2 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 09/18/2002 | EP0630249B1 Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof |
| 09/18/2002 | CN1370180A Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 09/10/2002 | CA2132449C 17 - substituted steroids useful in cancer treatment |
| 09/04/2002 | EP1236471A2 Angiostatic steroids |
| 09/04/2002 | EP1236470A2 Angiostatic steroids |
| 09/04/2002 | EP1236469A2 Angiostatic steroids |
| 09/04/2002 | EP1235849A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 08/07/2002 | EP1039912B1 Angiostatic agents and compositions for treating glc1a glaucoma |
| 07/25/2002 | US20020099202 Compoound for use in the sequencing of nucleic acids |
| 07/24/2002 | EP1224204A1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 07/23/2002 | US6423698 Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia |
| 07/17/2002 | EP1042353B1 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives |
| 07/10/2002 | CN1358193A Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/02/2002 | CA2064478C Ophthalmic composition |
| 06/25/2002 | US6410782 Bioavailability; side effect reduction; mixture with an aminoalcohol |
| 06/18/2002 | US6407083 Uses of novel organoselenium compounds with pro-oxidant activity |